Pfizer's Celebrex drug to add warning (Reuters)


Reuters - Pfizer Inc. on Monday said the
label of its Celebrex arthritis drug has been changed to add a
prominent warning of possible cardiovascular risks, such as
increased risk of heart attacks, in line with new warnings of
other arthritis and pain drugs.

Read more...